Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Mar;55(3):227–231. doi: 10.1038/bjc.1987.44

Drug-targeting by monoclonal antibodies.

M J Embleton
PMCID: PMC2001752  PMID: 3552013

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell A. M., McCormack M. A., Ross C. A., Leake R. E. Immunological analysis of the specificity of the autologous humoral response in breast cancer patients. Br J Cancer. 1986 Jan;53(1):7–11. doi: 10.1038/bjc.1986.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carrière D., Casellas P., Richer G., Gros P., Jansen F. K. Endocytosis of an antibody ricin A-chain conjugate (immuno-A-toxin) adsorbed on colloidal gold. Effects of ammonium chloride and monensin. Exp Cell Res. 1985 Feb;156(2):327–340. [PubMed] [Google Scholar]
  3. Casellas P., Bourrie B. J., Gros P., Jansen F. K. Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores. J Biol Chem. 1984 Aug 10;259(15):9359–9364. [PubMed] [Google Scholar]
  4. Casellas P., Canat X., Fauser A. A., Gros O., Laurent G., Poncelet P., Jansen F. K. Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin. Blood. 1985 Feb;65(2):289–297. [PubMed] [Google Scholar]
  5. Eiklid K., Olsnes S., Pihl A. Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res. 1980 Apr;126(2):321–326. doi: 10.1016/0014-4827(80)90270-0. [DOI] [PubMed] [Google Scholar]
  6. Embleton M. J. Targeting of anti-cancer therapeutic agents by monoclonal antibodies. Biochem Soc Trans. 1986 Apr;14(2):393–395. doi: 10.1042/bst0140393. [DOI] [PubMed] [Google Scholar]
  7. Filipovich A. H., Vallera D. A., Youle R. J., Quinones R. R., Neville D. M., Jr, Kersey J. H. Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease. Lancet. 1984 Mar 3;1(8375):469–472. doi: 10.1016/s0140-6736(84)92847-2. [DOI] [PubMed] [Google Scholar]
  8. Garnett M. C., Baldwin R. W. An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines. Cancer Res. 1986 May;46(5):2407–2412. [PubMed] [Google Scholar]
  9. Herlyn D. M., Steplewski Z., Herlyn M. F., Koprowski H. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res. 1980 Mar;40(3):717–721. [PubMed] [Google Scholar]
  10. Hurwitz E., Maron R., Bernstein A., Wilchek M., Sela M., Arnon R. The effect in vivo of chemotherapeutic drug--antibody conjugates in two murine experimental tumor systems. Int J Cancer. 1978 Jun 15;21(6):747–755. doi: 10.1002/ijc.2910210612. [DOI] [PubMed] [Google Scholar]
  11. Koprowski H., Herlyn D., Lubeck M., DeFreitas E., Sears H. F. Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Proc Natl Acad Sci U S A. 1984 Jan;81(1):216–219. doi: 10.1073/pnas.81.1.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Levy R., Miller R. A. Tumor therapy with monoclonal antibodies. Fed Proc. 1983 Jun;42(9):2650–2656. [PubMed] [Google Scholar]
  13. Pectasides D., Stewart S., Courtenay-Luck N., Rampling R., Munro A. J., Krausz T., Dhokia B., Snook D., Hooker G., Durbin H. Antibody-guided irradiation of malignant pleural and pericardial effusions. Br J Cancer. 1986 Jun;53(6):727–732. doi: 10.1038/bjc.1986.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ritz J., Pesando J. M., Sallan S. E., Clavell L. A., Notis-McConarty J., Rosenthal P., Schlossman S. F. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood. 1981 Jul;58(1):141–152. [PubMed] [Google Scholar]
  15. Rowland G. F., O'Neill G. J., Davies D. A. Suppression of tumour growth in mice by a drug-antibody conjugate using a novel approach to linkage. Nature. 1975 Jun 5;255(5508):487–488. doi: 10.1038/255487a0. [DOI] [PubMed] [Google Scholar]
  16. Thorpe P. E., Ross W. C. The preparation and cytotoxic properties of antibody-toxin conjugates. Immunol Rev. 1982;62:119–158. doi: 10.1111/j.1600-065x.1982.tb00392.x. [DOI] [PubMed] [Google Scholar]
  17. Vitetta E. S., Cushley W., Uhr J. W. Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6332–6335. doi: 10.1073/pnas.80.20.6332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vitetta E. S., Fulton R. J., Uhr J. W. Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain. J Exp Med. 1984 Jul 1;160(1):341–346. doi: 10.1084/jem.160.1.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Winger L., Winger C., Shastry P., Russell A., Longenecker M. Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4484–4488. doi: 10.1073/pnas.80.14.4484. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES